The Medicines and Healthcare products Regulatory Agency announced the re-appointment of Professor Sir Michael Rawlins as its Chair yesterday for a further 3 years.
Since taking up the position of chair at the Agency in 2014, Sir Michael has overseen the Agency’s work as an effective regulator of medicines and medical devices across the UK. He has promoted the first-class science and research carried out in each of the Agency’s centres; the National Institute for Biological Standards and Control (NIBSC), the Clinical Practice Research Datalink (CPRD) and MHRA.
Earlier this year, Professor Sir Michael Rawlins was appointed Knight Grand Cross of the Order of the British Empire (GBE) for the services to the safety of medicines, healthcare and innovation.
Professor Sir Michael Rawlins said:
“I am delighted to serve as the Agency’s Chair for a second term. One of the joys of this job is seeing each part of the Agency continue to deliver innovative science and protect public health.
“I am looking forward to taking on the next challenge, as we seek to continue to play a leading role in both Europe and the world on promoting public health.”
Chief Executive Dr Ian Hudson said:
“Sir Mike has overseen a very successful period in the Agency’s history, and I’m delighted to see his re-appointment, as we move into an equally crucial next stage.
“He has been at the forefront of innovation, development and leadership in the public health sector for more than 3 decades.”